BioCatalystWatch
ELDNWorkspace / ELDN / OverviewCompany library
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. (ELDN)

Website

Price
Market cap
Next catalystQ4 2026, subject to raising additional financingTegoprubart — LEGACY · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Tegoprubart

CD40L (CD154)

Upcoming / outlook

Tegoprubart

CD40L (CD154)

PreINDP1P2FilingApproved
Upcoming / outlook

Tegoprubart

CD40L (CD154)

Upcoming / outlook

Tegoprubart

CD40L (CD154)

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Tegoprubart

CD40L (CD154)

PreINDP1P2FilingApproved
Upcoming / outlook

Tegoprubart

CD40L (CD154)

Upcoming / outlook

Tegoprubart

CD40L (CD154)

Upcoming / outlook

Tegoprubart

CD40L (CD154)

Upcoming / outlook

Other pipelines

Tegoprubart

CD40L (CD154)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Tegoprubart

CD40L (CD154)

Tegoprubart

CD40L (CD154)

PreINDP1P2P3FilingApproved
Tegoprubart

CD40L (CD154)

PreINDP1P2P3FilingApproved

History / paused

Tegoprubart

CD40L (CD154)

PreINDP1P2P3FilingApproved
Tegoprubart

CD40L (CD154)

PreINDP1P2P3FilingApproved
Tegoprubart

CD40L (CD154)

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ELDN PR & News

PR & News

ELDN SEC archive